Tevis Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.75M | Buy |
39,862
+24,799
| +165% | +$1.71M | 1.76% | 16 |
|
|
2025
Q1 | $1.3M | Hold |
15,063
| – | – | 0.96% | 34 |
|
|
2024
Q4 | $1.3M | Sell |
15,063
-23
| -0.2% | -$1.98K | 0.96% | 34 |
|
|
2024
Q3 | $1.8M | Sell |
15,086
-222
| -1% | -$26.4K | 1.33% | 26 |
|
|
2024
Q2 | $2.19M | Sell |
15,308
-823
| -5% | -$117K | 1.76% | 17 |
|
|
2024
Q1 | $2.07M | Sell |
16,131
-875
| -5% | -$112K | 1.76% | 17 |
|
|
2023
Q4 | $1.76M | Buy |
17,006
+386
| +2% | +$39.9K | 1.62% | 19 |
|
|
2023
Q3 | $1.51M | Sell |
16,620
-8
| -0% | -$728 | 1.53% | 19 |
|
|
2023
Q2 | $1.35M | Sell |
16,628
-342
| -2% | -$27.7K | 1.31% | 24 |
|
|
2023
Q1 | $1.35M | Sell |
16,970
-3,468
| -17% | -$276K | 1.37% | 25 |
|
|
2022
Q4 | $1.38M | Sell |
20,438
-152
| -0.7% | -$10.3K | 1.47% | 23 |
|
|
2022
Q3 | $1.03M | Buy |
20,590
+420
| +2% | +$20.9K | 1% | 37 |
|
|
2022
Q2 | $1.12M | Buy |
20,170
+1,144
| +6% | +$63.7K | 1.07% | 33 |
|
|
2022
Q1 | $1.06M | Buy |
19,026
+138
| +0.7% | +$7.67K | 0.96% | 35 |
|
|
2021
Q4 | $1.06M | Buy |
+18,888
| New | +$1.06M | 0.92% | 33 |
|